Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in first-line metastatic colorectal cancer ...

California Atty. Gen. Rob Bonta filed suit against the genetic testing company formerly known as 23andMe for failing to ...

AI hiring compliance UK is now a live enforcement issue: the ICO closed its automated decision-making consultation tonight after finding most UK employers are non-compliant. Sixteen organisations have ...

Durability questions remain, but Myval appears comparable to contemporary devices on the market, says Patrick Serruys.

Now sites have a new way to spy on their visitors: measuring subtle interactions with their solid-state drives. The technique ...

Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap ...

A major new study, 'Catholic Generosity', will be launched early this summer, offering the most comprehensive analysis to date ...

Leveraging artificial intelligence and 15 years of data, TerraSIGNAL will extend access to agronomic expertise, using ...

AI-powered data analytics company Alphalyr won the 2026 ANDAM Innovation Prize while a special prize went to biobased dye and ...

NSCLC showed the largest reduction in metastatic progression with GLP-1RAs versus gliptins (HR 0.50), with significant ...

With megacap AI software names trading at triple-digit cash-flow multiples, value-oriented investors are quietly rotating ...

Revieve, the global leader in AI-powered beauty and wellness technology, today launches The Future Face of Beauty—a four-part ...